Clinical Trials
Positive Results From The Phase 2 AESOP Trial Evaluating OCA For The Treatment Of Patients With Primary Sclerosing Cholangitis Announced By Intercept
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, ...
Videos
Using Data to Battle America’s Deadliest Disease
Clinical research generates extensive amounts of data, yet most of it is siloed or generally unavailable to a larger pool of willing potential researchers....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read